Tags : Remitting

Immunic Reports Results of IMU-838 in P-II EMPhASIS Study in

Shots: The P-II EMPhASIS study involves assessing of IMU-838 in 210 patients randomized in 36 centers across 4 EU countries, 209 patients received at least one dose of IMU-838 vs PBO and 197 patients completed @24-wks. treatment period The study resulted in meeting its 1EPs & 2EPs: 62% & 70% reduction in CUA MRI lesions […]Read More